PUMA BIOTECHNOLOGY, INC. Quarterly Operating Income (Loss) in USD from Q3 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Puma Biotechnology, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2010 to Q2 2024.
  • Puma Biotechnology, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$2.18M, a 145% decline year-over-year.
  • Puma Biotechnology, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was $18.9M, a 12.7% decline year-over-year.
  • Puma Biotechnology, Inc. annual Operating Income (Loss) for 2023 was $32.6M, a 37.6% increase from 2022.
  • Puma Biotechnology, Inc. annual Operating Income (Loss) for 2022 was $23.7M, a 1739% increase from 2021.
  • Puma Biotechnology, Inc. annual Operating Income (Loss) for 2021 was $1.29M.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $18.9M -$2.18M -$7.07M -145% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $26M -$2.3M -$6.66M -153% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $32.6M $14.8M +$4.78M +47.7% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 $27.9M $8.59M +$6.19M +259% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $21.7M $4.89M -$7.17M -59.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 $28.8M $4.37M +$5.11M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 $23.7M $10M +$3.29M +48.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 $20.4M $2.39M +$11.3M Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $9.09M $12.1M +$28.7M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 -$19.6M -$747K -$20.9M -104% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $1.29M $6.73M +$17.9M Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 -$16.6M -$8.95M +$3.18M +26.2% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 -$19.8M -$16.6M -$23.8M -333% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $4M $20.1M +$34.4M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 -$30.4M -$11.1M -$2.48M -28.7% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-02
Q3 2020 -$27.9M -$12.1M +$2.32M +16% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 -$30.2M $7.13M +$32.9M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 -$63.1M -$14.3M -$24.1M -245% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 -$39M -$8.67M +$9.87M +53.3% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-03
Q3 2019 -$48.9M -$14.4M -$3.17M -28.1% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 -$45.7M -$25.8M +$15.7M +37.8% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 -$61.4M $9.85M +$33.2M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 -$94.7M -$18.5M +$45M +70.8% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-01
Q3 2018 -$140M -$11.3M +$66.2M +85.4% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 -$206M -$41.4M +$36.7M +47% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 -$243M -$23.4M +$49.8M +68% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 -$292M -$63.6M +$9.3M +12.8% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-28
Q3 2017 -$302M -$77.4M -$11.4M -17.3% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-05
Q2 2017 -$290M -$78.2M -$11.7M -17.6% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 -$279M -$73.2M -$1.96M -2.75% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 -$277M -$72.9M -$10.8M -17.5% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-01
Q3 2016 -$266M -$66M -$5.27M -8.67% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 -$260M -$66.5M -$1.57M -2.42% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 -$259M -$71.2M -$18.6M -35.5% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 -$240M -$62M -$14.4M -30.3% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-09
Q3 2015 -$226M -$60.7M -$24.8M -68.9% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 -$201M -$64.9M -$26M -66.9% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 -$175M -$52.6M -$32.8M -165% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 -$142M -$47.6M -$31.6M -198% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-01
Q3 2014 -$111M -$36M -$21.6M -151% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 -$89M -$38.9M -$26.2M -206% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-10
Q1 2014 -$62.8M -$19.8M -$8.01M -67.9% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
Q4 2013 -$54.8M -$16M +$5.96M +27.2% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-29
Q3 2013 -$60.8M -$14.3M +$11.5M +44.6% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-10
Q2 2013 -$72.3M -$12.7M +$2.07M +14% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-11
Q1 2013 -$74.4M -$11.8M +$46K +0.39% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
Q4 2012 -$74.5M -$21.9M -$12.2M -124% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-02
Q3 2012 -$62.3M -$25.9M -$25.5M -7648% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-12
Q2 2012 -$36.7M -$14.8M -$14.7M Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-06
Q1 2012 -$22M -$11.9M -$11.8M Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-09
Q4 2011 -$10.2M -$9.78M -$9.78M Oct 1, 2011 Dec 31, 2011 10-K 2014-03-03
Q3 2011 -$379K -$334K -$327K Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-14
Q2 2011 -$51.8K -$34.3K* Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-14
Q1 2011 -$3.94K* Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-15
Q4 2010 -$7K* Sep 16, 2010 Dec 31, 2010 10-K 2013-04-01
Q3 2010 -$6.63K* Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.